Product NDC: | 0574-0215 |
Proprietary Name: | Naratriptan Hydrochloride |
Non Proprietary Name: | Naratriptan Hydrochloride |
Active Ingredient(s): | 2.78 mg/1 & nbsp; Naratriptan Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0574-0215 |
Labeler Name: | Paddock Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091326 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100708 |
Package NDC: | 0574-0215-09 |
Package Description: | 1 BLISTER PACK in 1 CARTON (0574-0215-09) > 9 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 0574-0215-09 |
Proprietary Name | Naratriptan Hydrochloride |
Package Description | 1 BLISTER PACK in 1 CARTON (0574-0215-09) > 9 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 0574-0215 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Naratriptan Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100708 |
Marketing Category Name | ANDA |
Labeler Name | Paddock Laboratories, Inc. |
Substance Name | NARATRIPTAN HYDROCHLORIDE |
Strength Number | 2.78 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |